Alpha Tau Medical Ltd (DRTS) Stock Ticker
DRTS right now
Market factors today
Unlock the full DRTS picture
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
DRTS stock facts
| Ticker symbol | DRTS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.3B |
| CEO | Uzi Sofer |
| Employees | 121 |
| Headquarters | Jerusalem, JM, IL |
| IPO date | 2021-03-08 |
| Website | www.alphatau.com |
What you can see for DRTS on Tickr
Live DRTS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the DRTS report.
Rankings
FAQ
What is the ticker symbol for Alpha Tau Medical Ltd?
The ticker symbol for Alpha Tau Medical Ltd is DRTS, listed on the NASDAQ.
What is DRTS?
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical…